<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04533542</url>
  </required_header>
  <id_info>
    <org_study_id>I 471719</org_study_id>
    <secondary_id>NCI-2019-06972</secondary_id>
    <secondary_id>I 471719</secondary_id>
    <secondary_id>P30CA016056</secondary_id>
    <secondary_id>U54CA238110</secondary_id>
    <nct_id>NCT04533542</nct_id>
  </id_info>
  <brief_title>Nicotine Vapor Specific Sensory Measurement</brief_title>
  <official_title>Nicotine Vapor Specific Sensory Measurement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Roswell Park Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial aims to develop reliable and valid measures of sensory experiences unique to&#xD;
      e-cigarette use. Regardless of whether flavorings show evidence of toxicity in a biological&#xD;
      sense, they may nonetheless increase harm by other means, such as increasing appeal,&#xD;
      decreasing risk perceptions, or masking harshness or irritation that might lead users to&#xD;
      discontinue use.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. Study that flavors might be related to the phenomenon of 'indirect' toxicity.&#xD;
&#xD;
      OUTLINE: Participants are randomized to 1 of 2 conditions.&#xD;
&#xD;
      CONDITION I: Participants attend up to 3 video or telephone conferences over 2 hours each&#xD;
      with a minimum of 24 hours and maximum of 1 week between sessions. Participants take a fixed&#xD;
      number of puffs on 3 randomly assigned conditions (combinations of carrier and nicotine&#xD;
      concentrations).&#xD;
&#xD;
      CONDITION II: Participants attend up to 2 video or telephone conferences over 2 hours each&#xD;
      with a minimum of 24 hours and maximum of 1 week between sessions. Participants take a fixed&#xD;
      number of puffs on a nicotine-free condition and 3 randomly assigned conditions (combinations&#xD;
      of carrier concentration and nicotine form).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2021</start_date>
  <completion_date type="Anticipated">September 10, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 10, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensory response measures</measure>
    <time_frame>2 years</time_frame>
    <description>Will be assessed by product evaluation scale - Scale consists of 22 questions with #1 = Not at all - 7 = Extremely</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensory response measure</measure>
    <time_frame>2 years</time_frame>
    <description>gMLS rating of harshness, throat hit, and pleasantness.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Substance-Related Disorder</condition>
  <arm_group>
    <arm_group_label>Arm I (3 video or telephone conferences)</arm_group_label>
    <description>Participants attend up to 3 video or telephone conferences over 2 hours each with a minimum of 24 hours and maximum of 1 week between sessions. Participants take a fixed number of puffs on 3 randomly assigned conditions (combinations of carrier and nicotine concentrations).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (2 video or telephone conferences)</arm_group_label>
    <description>Participants attend up to 2 video or telephone conferences over 2 hours each with a minimum of 24 hours and maximum of 1 week between sessions. Participants take a fixed number of puffs on a nicotine-free condition and 3 randomly assigned conditions (combinations of carrier concentration and nicotine form).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measurement</intervention_name>
    <description>Undergo sensory measurements</description>
    <arm_group_label>Arm I (3 video or telephone conferences)</arm_group_label>
    <arm_group_label>Arm II (2 video or telephone conferences)</arm_group_label>
    <other_name>Measure</other_name>
    <other_name>{Measure}</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (3 video or telephone conferences)</arm_group_label>
    <arm_group_label>Arm II (2 video or telephone conferences)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants from general population in the greater Buffalo area and are current daily&#xD;
        vapers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current daily vapers of products containing nicotine&#xD;
&#xD;
          -  No concurrent use of other tobacco products&#xD;
&#xD;
          -  Self reported general good health&#xD;
&#xD;
          -  No allergies - specifically known active untreated seasonal allergies that would&#xD;
             interfere with smell or taste procedures&#xD;
&#xD;
          -  No self-reported taste or smell deficits&#xD;
&#xD;
          -  Not pregnant or lactating&#xD;
&#xD;
          -  No medications known to interfere with taste/smell (i.e.: certain nasal sprays, nasal&#xD;
             antihistamines, decongestants, antibiotics, medications containing zinc)&#xD;
&#xD;
          -  Passing scores on the phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell&#xD;
             and taste tests&#xD;
&#xD;
          -  Access to video-conference or telephone&#xD;
&#xD;
          -  Ability to store test products in a secure location away from children&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not current daily vapers&#xD;
&#xD;
          -  Concurrent use of other tobacco products&#xD;
&#xD;
          -  Self-reported fair or poor general health&#xD;
&#xD;
          -  Allergies - active untreated seasonal allergies that would interfere with smell or&#xD;
             taste procedures&#xD;
&#xD;
          -  Self-reported taste or smell deficits&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Medications known to interfere with taste/smell (i.e.: certain nasal sprays, nasal&#xD;
             antihistamines, decongestants, antibiotics, medications containing zinc)&#xD;
&#xD;
          -  Failing scores on the phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell&#xD;
             and taste tests&#xD;
&#xD;
          -  No access to video-conference or telephone&#xD;
&#xD;
          -  Unable to store test products in a secure location away from children&#xD;
&#xD;
          -  Individuals who are not yet adults (infants, children, teenagers)&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Adults unable to legally purchase tobacco products in New York (NY) state (18-20)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard J O'Connor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard J. O'Connor</last_name>
      <phone>716-845-4517</phone>
      <email>Richard.OConnor@roswellpark.org</email>
    </contact>
    <investigator>
      <last_name>Richard J. O'Connor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

